Collegium Pharmaceutical, Inc. COLL Symproic and other — 2028
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree.
The official record: Collegium Pharmaceutical, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s symproic and other — 2028.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s symproic and other — 2028?
- Collegium Pharmaceutical, Inc. (COLL) reported symproic and other — 2028 of $7.29M in Q4 2025.
- What does symproic and other — 2028 mean?
- Represents the projected or actual financial performance metric for the Symproic segment specifically for the fiscal year 2028. This data point assists in long-range financial planning and assessing the terminal value of the segment's intangible assets.